Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
暂无分享,去创建一个
W. Guan | J. Kaufman | D. Duprez | J. Stein | A. Karger | G. Thanassoulis | M. Tsai | B. Steffen | Mathew C Tattersall
[1] S. Grundy,et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[2] W. Guan,et al. Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups: The Multi-Ethnic Study of Atherosclerosis , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[3] R. Planken,et al. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease. , 2018, Journal of clinical lipidology.
[4] Yuan-Lin Guo,et al. Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia , 2018, Journal of clinical laboratory analysis.
[5] C. Yuan,et al. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Ou , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[6] M. Woodward,et al. Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC) , 2017, Journal of the American Heart Association.
[7] C. Gieger,et al. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms[S] , 2017, Journal of Lipid Research.
[8] César Martín,et al. PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia. , 2016, Atherosclerosis.
[9] B. Nordestgaard,et al. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology , 2016, Journal of Lipid Research.
[10] A. Hoes,et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.
[11] E. Fishman,et al. Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease. , 2016, The American journal of cardiology.
[12] W. Guan,et al. Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Zwinderman,et al. Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study. , 2016, European heart journal.
[14] M. Criqui,et al. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. , 2016, Journal of vascular surgery.
[15] J. Borén,et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment , 2015, European heart journal.
[16] W. Guan,et al. Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment: The Multi-Ethnic Study of Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[17] David Reich,et al. The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.
[18] Lianne Sheppard,et al. Predictors of Carotid Thickness and Plaque Progression During a Decade: The Multi-Ethnic Study of Atherosclerosis , 2014, Stroke.
[19] Mantian Chen,et al. Serum Lipoprotein(a) Positively Correlates with Coronary Artery Calcification in Low-Risk Chinese Han Patients: A Study from a Single Center , 2013, PloS one.
[20] Kathleen F. Kerr,et al. Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.
[21] C. Becker,et al. Lipoprotein (a) is independently correlated with coronary artery calcification. , 2013, European journal of internal medicine.
[22] M. Reilly,et al. Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. , 2011, International journal of cardiology.
[23] M. Taskinen,et al. [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.
[24] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[25] J. Borén,et al. Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.
[26] A. Khera,et al. Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study , 2009, Circulation.
[27] M. Koschinsky,et al. Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway* , 2008, Journal of Biological Chemistry.
[28] R. Kronmal,et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. , 2008, Atherosclerosis.
[29] M. Koschinsky,et al. Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[30] Jonathan C. Cohen,et al. Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study , 2005, Circulation.
[31] Manfred Dietel,et al. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries , 2005, Virchows Archiv A.
[32] E. Boerwinkle,et al. Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. , 2004, Mayo Clinic proceedings.
[33] L. Bielak,et al. Sex-specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[34] A. Scanu. Lp(a) lipoprotein--coping with heterogeneity. , 2003, The New England journal of medicine.
[35] T. Iwamoto,et al. Clinical significance of lipoprotein(a) in carotid plaque types and ischemic stroke in the elderly , 2003 .
[36] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[37] M. Nishino,et al. Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women. , 2000, Journal of the American College of Cardiology.
[38] E. Rubin,et al. Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. , 1997, The Journal of clinical investigation.
[39] E. Rubin,et al. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. , 1997, The Journal of clinical investigation.
[40] E. Wijsman,et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. , 1996, Journal of lipid research.
[41] G. Heiss,et al. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[42] S. Kiechl,et al. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. , 1995, Stroke.
[43] E. Boerwinkle,et al. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[44] U. Beisiegel,et al. Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques. , 1995, Atherosclerosis.
[45] Qi Chen,et al. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[46] A. Simon,et al. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[47] H. Hoff,et al. Quantification of apo[a] and apoB in human atherosclerotic lesions. , 1991, Journal of lipid research.
[48] V. Armstrong,et al. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. , 1990, Journal of lipid research.
[49] M. Dietel,et al. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.